NASDAQ · ATCX

Atlas Critical Minerals Corporation

$2.99 +$0.18 (+6.41%) 1D Market open

Key Metrics

$14.04M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow −$3.12M
Beta · 1Y 1.23
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 23
    From its Feb 3 high, the share price fell 68%.

    Peak close $8.68 on Feb 3; trough close $2.81 on Jul 23. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -68%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 31
    The stock moved +24.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 31
  • Feb 3
    The stock moved +29.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$14.04M
Enterprise value
Shares outstanding5.0M
52-wk range$2.79 – $14.01
Avg volume · 20D58.0K
Net cash
Book value / share$0.16
ExchangeNASDAQ
About Atlas Critical Minerals Corporation
IPO dateJul 3, 2018
Employees13

Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio0.39
Quick ratio0.37
Debt / equity
Debt / EBITDA
Net cash
Working capital−$1.11M

Cash Flow · TTM

Operating CF −$2.98M
Capex −$133.42K
Free cash flow −$3.12M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings